Patents by Inventor William Carroll

William Carroll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6538004
    Abstract: Compounds of formula I are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
    Type: Grant
    Filed: February 7, 2001
    Date of Patent: March 25, 2003
    Assignee: Abbott Laboratories
    Inventors: Irene Drizin, Robert J. Altenbach, William A. Carroll
  • Patent number: 6538000
    Abstract: Compounds of formula (I) are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
    Type: Grant
    Filed: November 10, 2000
    Date of Patent: March 25, 2003
    Assignee: Abbott Laboratories
    Inventors: Mark W. Holladay, William A. Carroll, Irene Drizin, Lin Yi, Henry Q. Zhang
  • Patent number: 6518279
    Abstract: Compounds of formula I are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
    Type: Grant
    Filed: March 4, 1999
    Date of Patent: February 11, 2003
    Assignee: Abbott Laboratories
    Inventors: William A. Carroll, Yiyuan Chen, Irene Drizin, James F. Kerwin, Jimmie L. Moore
  • Publication number: 20030018004
    Abstract: A vector comprising a nucleotide sequence of interest (“NOI”) encoding a product of interest (“POI”) is described. The NOI and/or the POI is capable of recognizing a tumor, such that in use the vector is capable of delivering the NOI and/or the POI to the tumor.
    Type: Application
    Filed: March 22, 2002
    Publication date: January 23, 2003
    Inventors: Susan Mary Kingsman, Christopher Robert Bebbington, Fiona Margaret Ellard, Miles William Carroll, Kevin Alan Myers
  • Patent number: 6503935
    Abstract: Compounds having formula I: are useful in treating diseases prevented by or ameliorated with &agr;1A agonists. Also disclosed are &agr;1A agonist compositions and a method of activating &agr;1 adrenoceptors in a mammal.
    Type: Grant
    Filed: July 29, 1999
    Date of Patent: January 7, 2003
    Assignee: Abbott Laboratories
    Inventors: Robert J. Altenbach, Michael D. Meyer, James F. Kerwin, Jr., Mark W. Holladay, Albert Khilevich, Teodozyj Kolasa, Jeffrey Rohde, William A. Carroll
  • Patent number: 6495576
    Abstract: Compounds of formula (I) may be useful in treating diseases prevented by or ameliorated with potassium channel openers.
    Type: Grant
    Filed: January 14, 2002
    Date of Patent: December 17, 2002
    Assignee: Abbott Laboratories
    Inventors: Michael E. Kort, Robert J. Gregg, William A. Carroll, Arturo Perez Medrano, Jürgen Dinges, Fatima Z. Basha
  • Publication number: 20020165264
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: January 14, 2002
    Publication date: November 7, 2002
    Inventors: Michael E. Kort, Robert J. Gregg, William A. Carroll, Arturo Perez Medrano, Jurgen Dinges, Fatima Z. Basha
  • Publication number: 20020147230
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: February 7, 2001
    Publication date: October 10, 2002
    Inventors: Michael E. Kort, Robert J. Gregg, William A. Carroll, Arturo Perez Medrano, Jurgen Dinges
  • Publication number: 20020028836
    Abstract: Compounds of formula I: 1
    Type: Application
    Filed: February 5, 2001
    Publication date: March 7, 2002
    Inventors: Robert J. Altenbach, Hao Bai, Jorge D. Brioni, William A. Carroll, Murali Gopalakrishnan, Robert J. Gregg, Mark W. Holladay, Peggy P. Huang, John F. Kincaid, Michael E. Kort, Philip R. Kym, John K. Lynch, Arturo Perez-Medrano, Henry Q. Zhang
  • Publication number: 20020007059
    Abstract: Compounds of formula I 1
    Type: Application
    Filed: February 7, 2001
    Publication date: January 17, 2002
    Inventors: Irene Drizin, Robert J. Altenbach, William A. Carroll
  • Publication number: 20020007065
    Abstract: Compounds of formula I 1
    Type: Application
    Filed: March 4, 1999
    Publication date: January 17, 2002
    Inventors: WILLIAM A. CARROLL, YIYUAN CHEN, IRENE DRIZIN, JAMES F. KERWIN, JIMMIE L. MOORE
  • Patent number: 6312683
    Abstract: A retroviral vector derived from a non-primate lentivirus genome comprising a deleted gag gene wherein the deletion in gag removes one or more nucleotides downstream of nucleotide 350 of the gag coding sequence.
    Type: Grant
    Filed: January 27, 1999
    Date of Patent: November 6, 2001
    Assignee: Oxford Biomedica (UK) Limited
    Inventors: Alan John Kingsman, Miles William Carroll, Jonathan Rohll, Kyriacos Mitrophanous, Narry Kim
  • Publication number: 20010036950
    Abstract: Compounds having the formula 1
    Type: Application
    Filed: May 25, 2001
    Publication date: November 1, 2001
    Inventors: William A. Carroll, Irene Drizin, Mark W. Holladay, James P. Sullivan, Henry Q. Zhang
  • Patent number: 6274587
    Abstract: Compounds of formula I are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
    Type: Grant
    Filed: November 19, 1999
    Date of Patent: August 14, 2001
    Assignee: Abbott Laboratories
    Inventors: Mark W. Holladay, William A. Carroll, Irene Drizin, Lin Yi, Henry Q. Zhang
  • Patent number: 6265417
    Abstract: Compounds having the formula are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: July 24, 2001
    Assignee: Abbott Laboratories
    Inventors: William A. Carroll, Irene Drizin, Mark W. Holladay, James P. Sullivan, Henry Q. Zhang
  • Patent number: 6191140
    Abstract: The present invention provides novel compounds of formula I which may be useful in hyperpolarizing cell membranes, opening potassium channels, relaxing smooth muscle cells, and inhibiting bladder contractions.
    Type: Grant
    Filed: October 20, 1999
    Date of Patent: February 20, 2001
    Assignee: Abbott Laboratories
    Inventors: William A. Carroll, Konstantinos A. Agrios, Robert J. Altenbach, Irene Drizin, Michael E. Kort
  • Patent number: 6153614
    Abstract: Compounds of Formula I ##STR1## and II and their pharmaceutically acceptable, salts, esters and prodrugs thereof are selective alpha-1D adrenoceptor anatagonists and may be useful for treating disease states, such as benign prostatic hyperplasia, detrusor insatbility, and incontinence.
    Type: Grant
    Filed: July 16, 1998
    Date of Patent: November 28, 2000
    Assignee: Abbott Laboratories
    Inventors: Michael D. Meyer, William A. Carroll
  • Patent number: 6088782
    Abstract: A Single Instruction Multiple Data processor apparatus for implementing algorithms using sliding window type data is shown. The implementation shifts the elements of a Destination Vector Register (406, 606) either automatically every time the destination register value is read or in response to a specific instruction (800). The shifting of the Destination Vector Register (406, 606) allows each processing element to operate on new data. As the destination vector (406, 606) elements are shifted, a new element is provided to the vector from a Source Vector Register (404, 604).
    Type: Grant
    Filed: July 10, 1997
    Date of Patent: July 11, 2000
    Assignee: Motorola Inc.
    Inventors: De-Lei Lee, L. Rodney Goke, William Carroll Anderson
  • Patent number: 6046207
    Abstract: The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a bicyclic heterocyclic ring system. The compounds are .alpha.-1 adrenergic antagonists and are useful in the treatment of BPH; also disclosed are .alpha.-1 antagonist compositions and a method for antagonizing .alpha.-1 adrenoreceptors and treating BPH.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: April 4, 2000
    Inventors: Michael D. Meyer, Robert J. Altenbach, Fatima Z. Basha, William A. Carroll, Irene Drizin, James F. Kerwin, Jr., Michael D. Wendt, Anthony R. Haight, Weijiang Zhang
  • Patent number: 6044392
    Abstract: A method and apparatus for performing rounding in a data processor (10). In one embodiment, two instructions are used to implement a procedure for rounding operands of finite but arbitrary precision. A first instruction "rndp" performs a preliminary rounding operation by analyzing bits which are less significant than the rounding point and updating the values of the round (RND) and sticky (STK) status bits (70, 71) in a defined manner. A second instruction "rnd" performs the rounding of the most significant portion of the operand, using the contents of the RND and STK status bits (70, 71) as determined by the one or more iterations of the "rndp" instruction. By appropriate use of these two instructions, and additional add-with-carry operations, an operand of any length may be rounded at an arbitrary point using a data processor (10) with fixed width registers (40) and a fixed width ALU (30).
    Type: Grant
    Filed: August 4, 1997
    Date of Patent: March 28, 2000
    Assignee: Motorola, Inc.
    Inventors: William Carroll Anderson, Thomas Joseph Tomazin